The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway ...

The development of bacterial vaccines has played a critical role in combating infectious diseases, significantly reducing mortality and morbidity worldwide.

Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

Attenuated Vaccines MarketThe global attenuated vaccines market is set for significant expansion, with sales projected to ...

The Central Drug Standards Control Organization (CDSCO) has granted a license to Biolumpivaxin, India’s first vaccine against ...

Bharat Biotech Group has announced its Lumpy Skin Disease (LSD) vaccine for dairy cattle and buffaloes, BIOLUMPIVAXIN has ...

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.